Recurrence of upper gastrointestinal bleeding after donepezil administration [3]

Alzheimer Disease and Associated Disorders

Volumn 20, Issue 4, 2006, Pages 326-

  Cholongitas, Evangelos ^a   Pipili, Chrysoula ^a   Dasenaki, Maria ^a  

^a General Hospital of Sitia   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; OMEPRAZOLE; PROTON PUMP INHIBITOR;

AGED; ALZHEIMER DISEASE; BACTERIUM DETECTION; CASE REPORT; DRUG WITHDRAWAL; EPIGASTRIC PAIN; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HEMATEMESIS; HUMAN; LETTER; MELENA; PRIORITY JOURNAL; RECURRENT DISEASE; RETREATMENT; STOMACH ULCER; TREATMENT DURATION; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTI-ULCER AGENTS; CHOLINESTERASE INHIBITORS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INDANS; MELENA; OMEPRAZOLE; PIPERIDINES; STOMACH ULCER;

EID: 33845410568     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000213851.59119.0b     Document Type: Letter

References (6)

1. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;1:CD005593.
2. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379-2388.
3. Winblad B, Kilander L, Eriksson S, et al. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet. 2006;367:1057-1065.
4. Rogers SL, Doody RS, Mohs RC, et al. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998;158:1021-1031.
5. Triot PN, Cummings JL, Katz IR, et al. Randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc. 2001;49:1590-1599.
6. Raschetti R, Maggini M, Sorrentino GC, et al. A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease. Eur J Clin Pharmacol. 2005;61:361-368.